Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • S-1 Filing
Posted on November 14, 2024

S-1 – NRX Pharmaceuticals, Inc. (0001719406) (Filer)

Filed: 2024-11-14 AccNo: 0001437749-24-035167 Size: 414 KB
Source: S-1 – NRX Pharmaceuticals, Inc. (0001719406) (Filer)

By sf-admin

Post navigation

Evolution Metals LLC and Welsbach Technology Metals Acquisition Corp Announce Filing of Registration Statement on Form S-4 Related to Proposed Business Combination
S-1/A – Moneyline Sports, Inc (0001989150) (Filer)


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace